The board of directors of wound-care management company Curative Health Services, Nashua, N.H., may be considering a sale, according to a news release issued by the company that said the directors have engaged investment bank UBS as financial adviser "to consider and analyze various strategic and financial alternatives." Curative did not return calls seeking comment.
Anne Barlow, an analyst covering Curative for investment bank Southwest Securities, earlier this month instructed shareholders to sell stock after the company reported second-quarter earnings that fell well below expectations. The company reported losses of $709,000 on revenue of $71.6 million for the quarter ended June 30. The company is having trouble collecting some payments from Medi-Cal, California's Medicaid program, and reported $222 million in debt at the end of the quarter, according to Barlow.